Translational Oncology · 2020 · 14 citations · 19 references
MedicineOncologyPathologyEndocrine OncologyGastrointestinal OncologyTumor ImmunologyCancer BiomarkersEndocrine Tumor PathologyGastric CancerMalignant NeoplasmsNeuroendocrine TumorsTumor MarkersBiomarkers Of Gastric CancerGastric Neuroendocrine NeoplasmsGastrointestinal Neuroendocrine TumorsMalignant ProgressionNeuroendocrine Tumor ClassificationNeuroendocrine Tumor HistologyPathology Of Gastric Cancer
PURPOSE: Dyslipidemia was associated with gastric adenocarcinoma or neuroendocrine tumors, but its role in a more malignant entity, gastric cancer with neuroendocrine immunophenotypes (GCNEI), was unclarified. This study sought to explore the relationship between serum lipid levels and the biological behaviors of gastric cancer with neuroendocrine immunophenotypes (GCNEI). METHODS: Patients with neuroendocrine carcinoma (NEC), GC with NEC components (GC-NEC), or GC expressing NE marker(s) but no NE morphology (GC-NENM) were enrolled from three centers. Their preoperative serum lipid levels, demographic, and clinicopathological information were analyzed and compared with those of patients with pure adenocarcinoma (PAC) or a background population selected from 10,061 health-check people by propensity-score matching. RESULTS: A total of 342 GCNEI patients were enrolled. Compared with the background population, total cholesterol (TCHO) and high-density lipoprotein cholesterol (HDL-C) levels were lower in GCNEI. Compared with PAC, GC-NENM and GC-NEC showed lower triglyceride (TG) levels, while, carcinoma with NE morphology showed higher low-density lipoprotein cholesterol (LDL-C) levels. Among GCNEI subtypes, GC-NEC differed from the others by higher LDL-C and non-HDL-C levels. A higher LDL-C level and(or) lower TG, HDL-C levels correlated to higher stages or large tumor sizes in GC-NENM, and a lower HDL-C level correlated to large tumor sizes in GC-NEC. A higher LDL-C level, lower TG, HDL-C, and non-HDL levels increased the risk of GC-NEC, and lower TG, and HDL-C levels increased the risk of GC-NENM and NEC. CONCLUSION: GCNEI had distinct and heterogeneous serum lipid patterns, which correlated to tumor development and progression.
19
The 2019 WHO classification of tumours of the digestive system
Irıs D. Nagtegaal, Robert D. Odze, David S. Klimstra et al. · Histopathology · 2019 · 4.1K citations · Full text
Fabian J. Brunner, Christoph Waldeyer, Francisco Ojeda et al. · The Lancet · 2019 · 296 citations · Full text
Devalkumar J. Rajyaguru, Andrew J. Borgert, Angela Smith et al. · Journal of Clinical Oncology · 2018 · 195 citations · Full text
Prognostic significance of neuroendocrine components in gastric carcinomas
Ji Y. Park, Min‐Hee Ryu, Young Soo Park et al. · European Journal of Cancer · 2014 · 74 citations